When the head of the Catholic Church faces a serious health scare, the world watches. In a rare double‑hit scenario, Pope Leo XIV is recuperating from a successful operation for lung adenocarcinoma, and at the same time his eldest brother, Louis Prevost, is battling multiple myeloma. The family’s own words, shared in recent interviews, underscore the emotional and logistical strain of confronting two serious cancers at once.

Background on the two diagnoses

The Vatican announced that the 71‑year‑old Pope, born Robert Francis Prevost, underwent a 90‑minute surgery at Rome’s Gemelli Hospital to remove a lower lobe of his right lung after a nodule was identified. The procedure was described as “successful” with no complications, and the pontiff woke up “feeling good” and spent a peaceful night in the hospital.

Meanwhile, Louis Prevost, the Pope’s older brother, has been living with multiple myeloma—a blood‑cancer that affects bone marrow and can damage kidneys. He was first diagnosed in 2017, received treatment in 2019, and fell out of remission three months ago. He is now part of a clinical trial in Florida that uses CAR‑T cell therapy, a technique that reprograms a patient’s immune cells to target blood cancers.

Medical context explained

Multiple myeloma is not currently considered curable, but survival rates have improved significantly over the past decade, according to the Multiple Myeloma Research Foundation. The disease’s impact on the blood and bone marrow can lead to complications such as kidney damage.

Lung adenocarcinoma is one of the most common forms of lung cancer, arising from mucus‑producing cells. Early detection improves prognosis, and modern treatments—including surgical resection and targeted therapies—have increased survival odds. The Pope’s operation removed the affected lobe, and the Vatican’s medical bulletin reported no immediate post‑operative issues.

Family impact and public statements

Deborah Prevost, wife of Louis Prevost, told CBS News (the BBC’s U.S. partner) that the family is “going through a lot.” She emphasized that they are “keeping spirits up for both of them,” reflecting a shared resolve despite the twin health challenges. Louis himself confirmed his diagnosis on the Newsmax program, describing the news of his brother’s surgery as a “shock.” He relayed a message from the Pope’s right‑hand that the pontiff was “awake, feeling good, and in no pain.”

The family’s openness offers a rare glimpse into the personal side of a papal household that is often shielded from public view. Their candid remarks serve both as a reassurance to the faithful and as a reminder that even the most prominent families confront ordinary fears and hopes.

Outlook and what lies ahead

For the Pope, the immediate outlook appears positive: the Vatican reported a smooth recovery and a return to his room after a brief observation period. Long‑term prognosis will depend on the cancer’s stage and the effectiveness of any adjuvant therapies.

Louis Prevost’s participation in a CAR‑T cell trial signals access to cutting‑edge treatment, which has shown promise in other blood‑cancer cases. While the therapy is still experimental, it represents a hopeful avenue for patients whose disease has relapsed.

Uncertainty and broader implications

Uncertainty remains regarding both men’s long‑term health trajectories. The source does not provide specific staging details for the Pope’s lung cancer or survival statistics for Louis’s multiple myeloma beyond the general improvement trend. Additionally, the emotional toll on the family, while described in broad terms, cannot be quantified from the available statements.

Beyond the personal narrative, the dual diagnoses highlight the importance of early detection, access to specialized care, and the role of clinical trials in offering new options for hard‑to‑treat cancers. As the Pope’s health is closely monitored by the Vatican’s medical team, and Louis’s treatment proceeds under a research protocol, both cases may influence public perception of cancer care and the value of innovative therapies.

In sum, the Prevost family is navigating a challenging period marked by two serious illnesses. Their public acknowledgment of the struggle, coupled with medical updates from reputable sources, provides a transparent window into the realities of confronting cancer at the highest levels of public life.